Results 221 to 230 of about 675,123 (288)
Some of the next articles are maybe not open access.
Cortistatin: not just another somatostatin analog
Nature Clinical Practice Endocrinology & Metabolism, 2006Cortistatin is a member of the somatostatin family of peptide hormones. Although cortistatin and somatostatin display many structural and functional similarities, there are also notable differences including tissue distribution and receptor selectivity.
Luis, de Lecea, Justo P, Castaño
openaire +2 more sources
Somatostatin analogs in ectopic corticotropin production
Metabolism, 1996Eutopic corticotroph pituitary adenomas and adrenal cortisol-producing adenomas do not usually express somatostatin receptors. However, ectopic corticotropin (ACTH)-producing tumors often express somatostatin receptors. Thus, the octreoscan can detect and localize tumors in 80% of patients with ectopic ACTH syndrome, and so it can be used to ...
K, von Werder, O A, Muller, G K, Stalla
openaire +2 more sources
Somatostatin Analogs Inhibit Neonatal Retinal Neovascularization
Experimental Eye Research, 2002The goal of this study was to determine the effect of two somatostatin analogs, Woc4D and octreotide, on oxygen induced retinopathy in the mouse. Oxygen induced retinopathy was produced in C57BL6 mice. Octreotide and Woc4D were administered from post-natal day 12-16.
Rosemary D, Higgins +2 more
openaire +2 more sources
Octreotide: A Long-Acting Somatostatin Analog
The American Journal of the Medical Sciences, 1990One of the exciting recent developments in endocrinology research has been the introduction of the somatostatin analog, octreotide into clinical practice. Octreotide provides a new therapeutic tool for diseases in which somatostatin or somatostatin-like products are secreted abnormally.
Nancy Brown +4 more
openaire +2 more sources
Targeted Radiotherapy with Radiolabeled Somatostatin Analogs
Endocrinology and Metabolism Clinics of North America, 2011Targeted radiopeptide therapy with (90)Yttrium- or (177)Lutetium-labeled somatostatin analogs has been proven to improve significantly quality of life and survival in patients suffering from metastatic or unresectable neuroendocrine tumors (NETs). Roughly 25% of patients achieve partial remission; progression-free survival is estimated to be 30 to 40 ...
Nicolas, Guillaume +3 more
openaire +2 more sources
Antiproliferative Effect of Somatostatin and Analogs
Chemotherapy, 2001Over the past decade, antiproliferative effects of somatostatin and analogs have been reported in many somatostatin receptor-positive normal and tumor cell types. Regarding the molecular mechanisms involved, somatostatin or analogs mediate their action through both indirect and direct effects.
C, Bousquet +4 more
openaire +2 more sources
Somatostatin analog treatment of pancreatic fistulas
International journal of pancreatology, 1993In order to hasten healing of pancreatic fistulas, we have treated 11 men and one woman with octreotide, a long-lasting somatostatin analog. This agent was administered subcutaneously in doses of 0.05-0.20 mg, two to three times per day. Fistulas were secondary to pancreatic biopsy (1), pancreatic abscess drainage (2), operative injury (3), and blunt ...
S M, Barnes, B G, Kontny, R A, Prinz
openaire +2 more sources
Radiolabeled somatostatin analogs in prostate cancer
Nuclear Medicine and Biology, 1997Vapreotide (RC-160), a somatostatin analog, was labeled with 99mTC by a direct method and also by using CPTA [1,4,8,11-tetraazacyclotetradecane] as a bifunctional chelating agent. The labeled compounds were evaluated in nude mice bearing experimental human prostate cancers. In these studies, 111In-DTPA-D-Phe-Octreotide (111In-DTPA-octreotide) served as
M L, Thakur +6 more
openaire +2 more sources
Two Types of Somatostatin Receptors Differentiated by Cyclic Somatostatin Analogs
Science, 1985Somatostatin receptors in rat brain, pituitary, and pancreas were labeled with two radioiodinated analogs of somatostatins 14 and 28. Two cyclic analogs of somatostatin, SMS201-995 and cyclo(Ala-Cys-Phe-D-Trp-Lys-Thr-Cys), showed biphasic displacement of binding to somatostatin receptors by these radioligands.
V T, Tran, M F, Beal, J B, Martin
openaire +2 more sources
Neuroscience, 1990
Rats chronically implanted with intrathecal catheters received intrathecal injections (10 microliters followed by 10 microliters saline flush) of either saline (n = 5), somatostatin (100 micrograms, n = 10), the somatostatin analog BIM 23003 (100 micrograms, n = 5), the somatostatin analog SMS 201-995 (100 micrograms, n = 5), the substance P analog [D ...
D M, Gaumann +4 more
openaire +2 more sources
Rats chronically implanted with intrathecal catheters received intrathecal injections (10 microliters followed by 10 microliters saline flush) of either saline (n = 5), somatostatin (100 micrograms, n = 10), the somatostatin analog BIM 23003 (100 micrograms, n = 5), the somatostatin analog SMS 201-995 (100 micrograms, n = 5), the substance P analog [D ...
D M, Gaumann +4 more
openaire +2 more sources

